Novel Executive Function Training for Obesity
- Conditions
- Overweight and Obesity
- Registration Number
- NCT03724396
- Lead Sponsor
- University of California, San Diego
- Brief Summary
Currently, the best behavioral treatments for obesity only work for 50% of adults, and of those who initially succeed, most do not maintain their weight loss. One reason for this failure may be due to neurocognitive deficits found among individuals with obesity, particularly related to executive function, which make it difficult for these adults to adhere to treatment recommendations. The proposed study aims to develop a Novel Executive Function Treatment (NEXT), which when administered prior to the behavioral treatment, could help improve outcomes by addressing the neurocognitive deficits in adults with overweight or obesity.
- Detailed Description
First, to assist with treatment development, two groups of approximately 10 participants will be enrolled in a 12-week open-label treatment group of NEXT. These participants will then provide qualitative feedback to help with treatment development. After the two pilot groups, a randomized control trial will evaluate NEXT compared to standard BWL to assess feasibility, acceptability and preliminary efficacy. Treatment will be 6 months long and assessments will occur at baseline, mid-treatment, post-treatment and 6-months after treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67
- Age 18-65
- Ability to read English at a 6th grade level
- BMI >25 and ≤45
- Difficulties with executive functioning
- Medical condition that requires physician monitoring to participate in weight control program or prohibits safely participating in recommended physical activity
- Psychiatric condition that could interfere with program participant (e.g., substance abuse, suicide attempt within previous 6 months, active purging)
- Currently pregnant, lactating or plan to be in the timespan of program follow-up
- Current enrollment in an organized weight control program
- Change in psychotropic medication or other medication that could have impact on weight during the previous 3 months
- History of bariatric surgery
- History of learning disorder, neurological condition or injury
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Acceptability At 6 months Ratings of usefulness of treatment
Feasibility as Measured by Attendance Over the course of 6 months of treatment Number of Treatment Sessions Attended
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
UCSD Center for Healthy Eating and Activity Research (CHEAR
🇺🇸La Jolla, California, United States
UCSD Center for Healthy Eating and Activity Research (CHEAR🇺🇸La Jolla, California, United States